🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Ruan et al - CC486 (oral aza) + CHOP 1L PTCL - 21 pts; 17 Tfh - med 66y, 90% stage III/IV - 10 had SCT - No CHOP dose ⬇️ - EOT: 75% ORR & CRR (88% AITL) - 1y PFS 66% (70% Tfh) - TET2 MAY suggest better prog; DNMT worse Small nos here - randomised trial coming. #ASH20 #lymsm

Mehta Shah et al huge dataset describing allogeneic stem cell transplantation in PTCL #ASH20 #lymSM particularly encouraging data for hepatosplenic T-cell lymphoma

Despite missing meetups with colleagues and friends, I must say that this year's #ASH20 is greatly enhanced by sweat pants and baby snuggles.

I feel bad for academics. You guys have to constantly come up with innovative ideas to advance medicine, meanwhile dudes in the 1800s were like “yo wash your hands” and became immediate professors at Harvard

I'm happy to have this published! This is a forward looking review of current and potential therapies in CTCL with a focus on targeting the tumor microenvironment. I hope you will find it interesting and useful... authors.elsevier.com/a/1chU68THnW0g…

Hanging out with the hospitalist

Anyone able to access this full article? Can't seem to get the full text despite multiple different attempts...

Spoiler. It's actually Evusheld. Will definitely need to have some in depth discussions about benefits with any patients who ask for it...

Nature does open access